Search

Bharati R Dhruva

Examiner (ID: 3913)

Most Active Art Unit
1632
Art Unit(s)
1632
Total Applications
2
Issued Applications
1
Pending Applications
1
Abandoned Applications
0

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4785079 [patent_doc_number] => 20080138408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'Drug delivery system and method' [patent_app_type] => utility [patent_app_number] => 11/985263 [patent_app_country] => US [patent_app_date] => 2007-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7881 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20080138408.pdf [firstpage_image] =>[orig_patent_app_number] => 11985263 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/985263
Drug delivery system and method Nov 12, 2007 Abandoned
Array ( [id] => 4613171 [patent_doc_number] => 07989426 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-02 [patent_title] => 'Selective induction of apoptosis to treat ocular disease by expression of PEDF' [patent_app_type] => utility [patent_app_number] => 11/938562 [patent_app_country] => US [patent_app_date] => 2007-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18407 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/989/07989426.pdf [firstpage_image] =>[orig_patent_app_number] => 11938562 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/938562
Selective induction of apoptosis to treat ocular disease by expression of PEDF Nov 11, 2007 Issued
Array ( [id] => 4915235 [patent_doc_number] => 20080095835 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-24 [patent_title] => 'Methods for treating cancers and restenosis with P21' [patent_app_type] => utility [patent_app_number] => 11/981179 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5967 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20080095835.pdf [firstpage_image] =>[orig_patent_app_number] => 11981179 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/981179
Methods for treating cancers and restenosis with P21 Oct 30, 2007 Abandoned
Array ( [id] => 4812883 [patent_doc_number] => 20080193514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'COMPOSTIONS AND METHODS FOR IONTOPHORESIS DELIVERY OF ACTIVE INGREDIENTS THROUGH HAIR FOLLICLES' [patent_app_type] => utility [patent_app_number] => 11/929451 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8295 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20080193514.pdf [firstpage_image] =>[orig_patent_app_number] => 11929451 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/929451
COMPOSTIONS AND METHODS FOR IONTOPHORESIS DELIVERY OF ACTIVE INGREDIENTS THROUGH HAIR FOLLICLES Oct 29, 2007 Abandoned
Array ( [id] => 6263199 [patent_doc_number] => 20100297214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'PERCOLATIVE DRYING FOR THE PREPARATION OF PARTICLES' [patent_app_type] => utility [patent_app_number] => 12/445719 [patent_app_country] => US [patent_app_date] => 2007-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11808 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297214.pdf [firstpage_image] =>[orig_patent_app_number] => 12445719 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/445719
PERCOLATIVE DRYING FOR THE PREPARATION OF PARTICLES Oct 25, 2007 Abandoned
Array ( [id] => 4676253 [patent_doc_number] => 20080213883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'SILICA NANOPARTICLES IN BASIC AMINO ACID-SILICA SOLS' [patent_app_type] => utility [patent_app_number] => 11/925299 [patent_app_country] => US [patent_app_date] => 2007-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 12744 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213883.pdf [firstpage_image] =>[orig_patent_app_number] => 11925299 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/925299
Forming nanoparticles in basic amino acid sols Oct 25, 2007 Issued
Array ( [id] => 4892932 [patent_doc_number] => 20080102030 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-01 [patent_title] => 'PARTICLES FOR CELL TARGETING' [patent_app_type] => utility [patent_app_number] => 11/870077 [patent_app_country] => US [patent_app_date] => 2007-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8604 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20080102030.pdf [firstpage_image] =>[orig_patent_app_number] => 11870077 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/870077
Particles for cell targeting Oct 9, 2007 Issued
Array ( [id] => 6608048 [patent_doc_number] => 20100099149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'STABILIZING COMPOSITIONS AND METHODS FOR EXTRACTION OF RIBONUCLEIC ACID' [patent_app_type] => utility [patent_app_number] => 12/444447 [patent_app_country] => US [patent_app_date] => 2007-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 17489 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20100099149.pdf [firstpage_image] =>[orig_patent_app_number] => 12444447 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/444447
STABILIZING COMPOSITIONS AND METHODS FOR EXTRACTION OF RIBONUCLEIC ACID Oct 4, 2007 Abandoned
Array ( [id] => 4832950 [patent_doc_number] => 20080131497 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'Formulations of DNase and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 11/864127 [patent_app_country] => US [patent_app_date] => 2007-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10215 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20080131497.pdf [firstpage_image] =>[orig_patent_app_number] => 11864127 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/864127
Formulations of DNase and Methods of Use Thereof Sep 27, 2007 Abandoned
Array ( [id] => 4550230 [patent_doc_number] => 07960525 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-14 [patent_title] => 'Gene repair involving in vivo excision of targeting DNA' [patent_app_type] => utility [patent_app_number] => 11/904034 [patent_app_country] => US [patent_app_date] => 2007-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9965 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/960/07960525.pdf [firstpage_image] =>[orig_patent_app_number] => 11904034 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/904034
Gene repair involving in vivo excision of targeting DNA Sep 24, 2007 Issued
Array ( [id] => 7650844 [patent_doc_number] => 20110300113 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'Death Receptor CD95 Controls Neurogenesis of Adult Neural Stem Cells in Vivo and in Vitro' [patent_app_type] => utility [patent_app_number] => 12/442017 [patent_app_country] => US [patent_app_date] => 2007-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12713 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20110300113.pdf [firstpage_image] =>[orig_patent_app_number] => 12442017 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/442017
Death Receptor CD95 Controls Neurogenesis of Adult Neural Stem Cells in Vivo and in Vitro Sep 18, 2007 Abandoned
Array ( [id] => 5569828 [patent_doc_number] => 20090253206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'NUCLEAR TRANSPORT AGENT AND METHOD FOR PRODUCING SAID AGENT' [patent_app_type] => utility [patent_app_number] => 12/440416 [patent_app_country] => US [patent_app_date] => 2007-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 6992 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20090253206.pdf [firstpage_image] =>[orig_patent_app_number] => 12440416 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/440416
NUCLEAR TRANSPORT AGENT AND METHOD FOR PRODUCING SAID AGENT Sep 12, 2007 Abandoned
Array ( [id] => 8845761 [patent_doc_number] => 08454937 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-04 [patent_title] => 'Method and composition for the site-selective delivery using viruses encapsulated in microbubbles' [patent_app_type] => utility [patent_app_number] => 11/894821 [patent_app_country] => US [patent_app_date] => 2007-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17124 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11894821 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/894821
Method and composition for the site-selective delivery using viruses encapsulated in microbubbles Aug 21, 2007 Issued
Array ( [id] => 6071354 [patent_doc_number] => 20110046205 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'METHOD FOR DISSOLVING CHARGED NUCLEIC ACID IN AN ORGANIC LIQUID' [patent_app_type] => utility [patent_app_number] => 12/377769 [patent_app_country] => US [patent_app_date] => 2007-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4206 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 41 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20110046205.pdf [firstpage_image] =>[orig_patent_app_number] => 12377769 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/377769
METHOD FOR DISSOLVING CHARGED NUCLEIC ACID IN AN ORGANIC LIQUID Aug 15, 2007 Abandoned
Array ( [id] => 7518718 [patent_doc_number] => 07972819 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-05 [patent_title] => 'Method and apparatus for disrupting cells and amplifying nucleic acids using gold nanorods' [patent_app_type] => utility [patent_app_number] => 11/838550 [patent_app_country] => US [patent_app_date] => 2007-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5827 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/972/07972819.pdf [firstpage_image] =>[orig_patent_app_number] => 11838550 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/838550
Method and apparatus for disrupting cells and amplifying nucleic acids using gold nanorods Aug 13, 2007 Issued
61/190065 Composition, method of preparation & application of concentrated formulations of condensed nucleic acids with a cationic lipopolymer Aug 5, 2007 Pending
Array ( [id] => 5027961 [patent_doc_number] => 20070269408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'GENES OF IL-12p40 SUBUNIT MUTATED FOR IMPROVING THE ACTIVITY OF IL-12 AND USE THEREOF FOR DNA VACCINE ADJUVANT' [patent_app_type] => utility [patent_app_number] => 11/832993 [patent_app_country] => US [patent_app_date] => 2007-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15351 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20070269408.pdf [firstpage_image] =>[orig_patent_app_number] => 11832993 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/832993
Genes of IL-12P40 subunit mutated for improving the activity of IL-12 and use thereof for DNA vaccine adjuvant Aug 1, 2007 Issued
Array ( [id] => 5557827 [patent_doc_number] => 20090269404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'Crosslinked Gelatin Gel, Multilayered Structure, Carrier for Bioactive Factor, Preparation for Release of Bioactive Factor, and Their Production Methods' [patent_app_type] => utility [patent_app_number] => 12/375920 [patent_app_country] => US [patent_app_date] => 2007-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11255 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20090269404.pdf [firstpage_image] =>[orig_patent_app_number] => 12375920 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/375920
Crosslinked Gelatin Gel, Multilayered Structure, Carrier for Bioactive Factor, Preparation for Release of Bioactive Factor, and Their Production Methods Jul 30, 2007 Abandoned
Array ( [id] => 4693097 [patent_doc_number] => 20080085868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-10 [patent_title] => 'Monoclonal Antibody 3F1H10 Neutralising VHSV (Viral Haemorrhagic Septicaemia Virus)' [patent_app_type] => utility [patent_app_number] => 11/829201 [patent_app_country] => US [patent_app_date] => 2007-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4408 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20080085868.pdf [firstpage_image] =>[orig_patent_app_number] => 11829201 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/829201
Monoclonal Antibody 3F1H10 Neutralising VHSV (Viral Haemorrhagic Septicaemia Virus) Jul 26, 2007 Abandoned
Array ( [id] => 4909693 [patent_doc_number] => 20080020459 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-24 [patent_title] => 'PROGENITOR CELL POPULATIONS, EXPANSION THEREOF, AND GROWTH OF NON-HEMATOPOIETIC CELL TYPES AND TISSUES THEREFROM' [patent_app_type] => utility [patent_app_number] => 11/828575 [patent_app_country] => US [patent_app_date] => 2007-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 12459 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20080020459.pdf [firstpage_image] =>[orig_patent_app_number] => 11828575 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/828575
Progenitor cell populations, expansion thereof, and growth of non-hematopoietic cell types and tissues therefrom Jul 25, 2007 Issued
Menu